atazanavir has been researched along with chir 258 in 1 studies
| Studies (atazanavir) | Trials (atazanavir) | Recent Studies (post-2010) (atazanavir) | Studies (chir 258) | Trials (chir 258) | Recent Studies (post-2010) (chir 258) |
|---|---|---|---|---|---|
| 75 | 1 | 37 | 29 | 0 | 24 |
| Protein | Taxonomy | atazanavir (IC50) | chir 258 (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.339 | |
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | 0.0808 | |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 0.002 | |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | 0.0162 | |
| Hepatocyte growth factor receptor | Homo sapiens (human) | 0.0011 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.003 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.0134 | |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | 0.0088 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.0065 | |
| Fibroblast growth factor receptor 3 | Homo sapiens (human) | 0.0075 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0045 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0303 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.002 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
1 review(s) available for atazanavir and chir 258
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |